Jacob N. Wohlstadter
Jacob N. Wohlstadter publishes mostly in Molecular Biology, Infectious Diseases and Physiology, on topics such as Advanced Biosensing Techniques and Applications, Advanced biosensing and bioanalysis techniques and Alzheimer's disease research and treatments.
- World rank
- #1,550,352 of 7,710,434 ranked researchers
- Rank in United States
- #484,071 of 1,627,098
- Works
- 78
- Citations
- 1.1k
- Citations per work
- 14.4
What does Jacob N. Wohlstadter research?
Jacob N. Wohlstadter's work is mostly in Biochemistry, Genetics and Molecular Biology (27%), Medicine (21%), Engineering (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3444.0%
- Life Sciences2430.8%
- Health Sciences1620.7%
- Medicine1620.7%
- Physical Sciences44.5%
- Engineering44.5%
- 1Molecular Biology27% of their works
- 2Infectious Diseases11% of their works
- 3Physiology6% of their works
- 4Biomedical Engineering4% of their works
- 5Radiology, Nuclear Medicine and Imaging4% of their works
- 6Immunology4% of their works
Research topics
- Advanced Biosensing Techniques and Applications
- Advanced biosensing and bioanalysis techniques
- Alzheimer's disease research and treatments
- SARS-CoV-2 and COVID-19 Research
- Monoclonal and Polyclonal Antibodies Research
- COVID-19 Clinical Research Studies
- Biosensors and Analytical Detection
- vaccines and immunoinformatics approaches
Which keywords describe Jacob N. Wohlstadter's research?
The keywords of their largest research topics: Biosensors, ACE2 Receptor, SARS-CoV-2, High-Throughput Analysis, Protein Microarrays, DNA nanotechnology, Self-Assembly and Amyloid Hypothesis.
- Epitope Prediction
- Loop-Mediated Isothermal Amplification
- Clinical Characteristics
- Therapeutic Antibodies
- Coronavirus
- Amyloid Hypothesis
- DNA nanotechnology
- High-Throughput Analysis
- ACE2 Receptor
- Biosensors
- SARS-CoV-2
- Protein Microarrays
- Self-Assembly
- Tau Pathology
- Fc Receptors
- Vaccine
- Epidemiology
- Paper-Based Microfluidics
- Peptide-MHC Binding
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Biosensors172 topics
- ACE2 Receptor162 topics
- SARS-CoV-2162 topics
- High-Throughput Analysis131 topic
- Protein Microarrays131 topic
- DNA nanotechnology111 topic
- Self-Assembly111 topic
- Amyloid Hypothesis101 topic
- Tau Pathology101 topic
- Coronavirus91 topic
- Fc Receptors91 topic
- Therapeutic Antibodies91 topic
- Vaccine91 topic
- Clinical Characteristics71 topic
- Epidemiology71 topic
- Loop-Mediated Isothermal Amplification61 topic
- Paper-Based Microfluidics61 topic
- Epitope Prediction51 topic
- Peptide-MHC Binding51 topic
Where does Jacob N. Wohlstadter work?
Jacob N. Wohlstadter's main affiliation in the publication record is Meso Scale Discovery (United States), United States.
How many publications and citations does Jacob N. Wohlstadter have?
OpenAlex counts 78 works and 1,123 citations for Jacob N. Wohlstadter, an h-index of 10, ranking #1,550,352 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jacob N. Wohlstadter. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.